The prevalence of Graves’ disease and related factors recurrence following discontinuation of antithyroid agents

S Kalantary

Journal of Inflammatory Diseases

The Official Journal of Qazvin University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Publication Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

The prevalence of Graves’ disease and related factors recurrence following discontinuation of antithyroid agents

Author(s):

S Kalantary^,*

Journal of Inflammatory Diseases:Vol. 8, issue 4; 45-48

Published online:Mar 31, 2005

Article type:Research Article

How to Cite:Kalantary S. The prevalence of Graves’ disease and related factors recurrence following discontinuation of antithyroid agents. J Inflamm Dis. 2024;8(4):e155096. doi:

Abstract

Abstract Background: Although iodine supply has reached to adequate levels in the recent years in Iran, it is evidently lower than the amount in western countries and USA. Some studies indicate that the quantity of iodine supplies present in food substances is effective in the recurrence of Graves’ disease. Objective: To determine the prevalence of Graves’ recurrence and related factors following dicontinuation of antithyroid agents. Methods: In a cross-sectional study based on easy sampling, 204 euthyroid out patients with Graves’ disease, treated with methimazole for 12-59 months, were selected and evaluated for the reccurence of disease a year later following the continuation of therapy. Parameters likes age, goiter size at the beginning and end of the treatment, severity of disease (T4 value), drug maintenance dose and the duration of treatment were studied. T test and X2 were used to analysis the data statistically. Findings: The one-year prevalence of disease recurrence following the medicine withdrawal was 44.6%, with a duration of 1-12 months (mean=7). There was no significant relation between the recurrence of disease and the age, sex, maintenance dose, goiter size before and after the treatment and also the T4 value at the beginning and the duration of treatment. Conclusion: The one-year prevalence of Graves’ disease recurrence following antithyroids withdrawal was significantly lower than the values in countries with rich iodine supplies. This finding is in accord with studies indicating that the level of iodine intake is effective in the recurrence of Graves’ disease.

Keywords

Keywords: Graves’ Disease

Long-term follow-up for the results of the treatment with Anti-Thyroid Drugs, Radioactive iodine and surgery in patients with Graves, disease

13

Jun

2020

International Journal of Endocrinology and Metabolism

Remission Rate of Graves' Disease and the Trend of Changes in Serum TSH Receptor Antibodies in Prolonged Antithyroid Drug Treatment

Danilo Villagelin,

Roberto Bernardo Santos,

João Hamilton Romaldini

Villagelin D, Santos RB, Romaldini JH. Remission Rate of Graves' Disease and the Trend of Changes in Serum TSH Receptor Antibodies in Prolonged Antithyroid Drug Treatment. Int J Endocrinol Metab. 2020;18(Suppl):e101473. doi: https://doi.org/10.5812/ijem.101473

14

Jun

2020

Long-Term Antithyroid Drug Treatment: Trends in Serum TSH and TSH Receptor Antibody Changes in Patients with Graves’ Disease

Ken Okamura,

Sachiko Bandai,

Megumi Fujikawa,

Kaori Sato,

Hiroshi Ikenoue,

Takanari Kitazono

Okamura K, Bandai S, Fujikawa M, Sato K, Ikenoue H, et al. Long-Term Antithyroid Drug Treatment: Trends in Serum TSH and TSH Receptor Antibody Changes in Patients with Graves’ Disease. Int J Endocrinol Metab. 2020;18(Suppl):e101139. doi: https://doi.org/10.5812/ijem.101139

31

Jan

2026

Sustained Control of Hyperthyroidism in Graves’ Disease: Comparison of Thyroidectomy and Long-Term Antithyroid Treatment

Hengameh Abdi,

Miralireza Takyar,

Ladan Mehran,

Safdar Masoumi,

Atieh Amouzegar,

Fereidoun Azizi

29

Jun

2020

Prediction of Relapse After Antithyroid Drugs Withdrawal: A Narrative Review

Pei-Wen Wang

Wang P. Prediction of Relapse After Antithyroid Drugs Withdrawal: A Narrative Review. Int J Endocrinol Metab. 2020;18(Suppl):e102346. doi: https://doi.org/10.5812/ijem.102346

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 1 week ago
Scopus by Title: 0
Last Update: 1 week ago
Scopus by Title (Ref): 0
Last Update: 1 week ago
CrossRef: 0
Last Update: 3 days ago

Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

S Kalantary:[PubMed][Scholar]

The Official Journal of Qazvin University of Medical Sciences

Outlines

The prevalence of Graves’ disease and related factors recurrence following discontinuation of antithyroid agents

Abstract

Similar Articles

Long-term follow-up for the results of the treatment with Anti-Thyroid Drugs, Radioactive iodine and surgery in patients with Graves, disease

Remission Rate of Graves' Disease and the Trend of Changes in Serum TSH Receptor Antibodies in Prolonged Antithyroid Drug Treatment

Long-Term Antithyroid Drug Treatment: Trends in Serum TSH and TSH Receptor Antibody Changes in Patients with Graves’ Disease

Sustained Control of Hyperthyroidism in Graves’ Disease: Comparison of Thyroidectomy and Long-Term Antithyroid Treatment

Prediction of Relapse After Antithyroid Drugs Withdrawal: A Narrative Review

Last Update: 1 week ago

Last Update: 1 week ago

Last Update: 1 week ago

Last Update: 3 days ago